Two debuts of note: Samsung’s Galaxy Ring, Watch upgrades; Alivecor’s InstantQT+KardiaMobile 6L Europe launch

Samsung’s big reveal at Unpacked in Paris today was the new Galaxy Ring device and health enhancements to the Galaxy Watch. Lots of health tracking features powered by Galaxy AI are packed into both that work best (of course) in the Samsung Health ecosystem, such as ring and watch together with Galaxy phones. General availability is 24 July. A topline review:

Galaxy Ring

–Accelerometer, optical heart rate sensor (including green, red, and infrared LEDs), and skin temperature sensor
–Sleep monitoring: movement during sleep, sleep latency, heart and respiratory rate. Quality of sleep analysis.
–Menstrual cycle via skin temperature tracking.
–Heart rate when unusually high or low, plus real time heart rate checking
–Exercise and the kind of workout or activity a person is doing
–Pricing at $399.99, available today at Samsung, Amazon, and Best Buy today, all other retailers 24 July. Size of ring is around 2.3 to 3 grams, depending on ring size (Samsung provides sizers). It’s also charged in a special dock and a single charge can last up to seven days.

Galaxy Watch 7 ($299) and Galaxy Watch Ultra (for athletes, $649)

–BioActive sensors for preventative care, capabilities to obtain more accurate health measurements, advanced athletic tracking capabilities and an emergency siren.
–Modifications to the photodiodes for more accurate data capture
–Blood oxygen levels, sleep quality, stress levels, heart rate

Data from both the Ring and Watch tie into Samsung Health apps that monitor blood pressure (CE Marked for EU), FDA-cleared ECG, and de novo clearance for detecting signs of sleep apnea. There is also a biomarker index, Advanced Glycation End Products (AGEs) Index, that indicates metabolic health and biological age markers.

More details: CNBC, The Verge, Mobihealthnews, Samsung release

Alivecor launches InstantQT in Europe. Used with Alivecor’s KardiaMobile 6L device and the KardiaStation app, InstantQT remotely records a point-of-care ECG and evaluates patients for potential cardiac abnormalities – all in less than one minute.  QT represents the time it takes for the heart muscle to contract and then recover (the electrical activity between the Q and T waves). Many medications can prolong that time leading to arrhythmias and potentially sudden heart failure. For monitoring those on antipsychotic medications and some cancer treatments, the quick evaluation by the patient using the KardiaMobile 6L device with the KardiaStation professional app can be performed on iOS devices. The InstantQT measurements are made using the EK12 ECG algorithm from GE HealthCare. Release

 

Categories: Latest News.

Leave a Reply

Your email address will not be published. Required fields are marked *